A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer
NCT04254497
·
clinicaltrials.gov ↗
COMPLETED
Status
71
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DIAGNOSTIC_TEST:
EGFR mutation detection kit
Sponsor
Changi General Hospital